Clinical and Metabolic Determinants of Hepatic Fibrosis in Patients with Metabolic Dysfunction- Associated Steatotic Liver Disease (MASLD) – Insights from a Bangladeshi Cohort. (2025). The Insight, 8(03), 588-592. https://doi.org/10.5281/zenodo.18014065